Human-specific regulation of MeCP2 levels in fetal brains by microRNA miR-483-5p

Genes and Development

Volumn 27, Issue 5, 2013, Pages 485-490

  Han, Kihoon ^a,b   Gennarino, Vincenzo Alessandro ^a,b   Lee, Yoontae ^a,b,g   Pang, Kaifang ^a,b   Hashimoto Torii, Kazue ^c,h,i   Choufani, Sanaa ^d   Raju, Chandrasekhar S ^e   Oldham, Michael C ^e   Weksberg, Rosanna ^d,f   Rakic, Pasko ^c   Liu, Zhandong ^a,b   Zoghbi, Huda Y ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g Pohang University of Science and Technology (POSTECH)   (South Korea)

^h CHILDREN S RESEARCH INSTITUTE   (United States)

ⁱ GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

3' UTR; HDAC4; Human fetal brain; MeCP2; miR 483 5p; TBL1X

Indexed keywords

HISTONE DEACETYLASE 4; METHYL CPG BINDING PROTEIN 2; MICRORNA; MICRORNA 483 5P; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; BRAIN DEVELOPMENT; BRAIN FUNCTION; CORRELATIONAL STUDY; DENDRITIC SPINE; FETUS DEVELOPMENT; GENETIC REGULATION; GENETIC TRANSCRIPTION; HUMAN; NERVE CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

BINDING SITES; BRAIN; CELL LINE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOMIC IMPRINTING; HUMANS; METHYL-CPG-BINDING PROTEIN 2; MICRORNAS; NEURONS; PROTEIN BINDING;

EID: 84874895206     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.207456.112     Document Type: Article

References (32)

1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23: 185-188.
2. Balmer D, Goldstine J, Rao YM, LaSalle JM. (2003). Elevated methyl-CpGbinding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J Mol Med (Berl) 81: 61-68.
3. Chahrour M, Zoghbi HY. (2007). The story of Rett syndrome: From clinic to neurobiology. Neuron 56: 422-437.
4. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY. (2008). MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320: 1224-1229.
5. Chao HT, Zoghbi HY. (2012). MeCP2: Only 100% will do. Nat Neurosci 15: 176-177.
6. Cheval H, Guy J, Merusi C, De Sousa D, Selfridge J, Bird A. (2012). Postnatal inactivation reveals enhanced requirement for MeCP2 at distinct age windows. Hum Mol Genet 21: 3806-3814.
7. Collins AL, Levenson JM, Vilaythong AP, Richman R, Armstrong DL, Noebels JL, David Sweatt J, Zoghbi HY. (2004). Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 13: 2679-2689.
8. Coy JF, Sedlacek Z, Bachner D, Delius H, Poustka A. (1999). A complex pattern of evolutionary conservation and alternative polyadenylation within the long 39-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum Mol Genet 8: 1253-1262.
9. del Gaudio D, Fang P, Scaglia F, Ward PA, Craigen WJ, Glaze DG, Neul JL, Patel A, Lee JA, Irons M, et al. (2006). Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet Med 8: 784-792.
10. Fischle W, Dequiedt F, Hendzel MJ, Guenther MG, Lazar MA, Voelter W, Verdin E. (2002). Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell 9: 45-57.
11. Gennarino VA, D'Angelo G, Dharmalingam G, Fernandez S, Russolillo G, Sanges R, Mutarelli M, Belcastro V, Ballabio A, Verde P, et al. (2012). Identification of microRNA-regulated gene networks by expression analysis of target genes. Genome Res 22: 1163-1172.
12. Gicquel C, Le Bouc Y. (2006). Hormonal regulation of fetal growth. Horm Res 65: 28-33.
13. Guy J, Cheval H, Selfridge J, Bird A. (2011). The role of MeCP2 in the brain. Annu Rev Cell Dev Biol 27: 631-652.
14. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Landsberger N, Strouboulis J, Wolffe AP. (1998). Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat Genet 19: 187-191.
15. Kent L, Bowdin S, Kirby GA, Cooper WN, Maher ER. (2008). Beckwith Weidemann syndrome: A behavioral phenotype-genotype study. Am J Med Genet B Neuropsychiatr Genet 147B: 1295-1297.
16. Klein ME, Lioy DT, Ma L, Impey S, Mandel G, Goodman RH. (2007). Homeostatic regulation of MeCP2 expression by a CREB-induced microRNA. Nat Neurosci 10: 1513-1514.
17. Kosik KS. (2006). The neuronal microRNA system. Nat Rev Neurosci 7: 911-920.
18. Kuhn DE, Nuovo GJ, Terry AV Jr, Martin MM, Malana GE, Sansom SE, Pleister AP, Beck WD, Head E, Feldman DS, et al. (2010). Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. J Biol Chem285: 1529-1543.
19. Ma N, Wang X, Qiao Y, Li F, Hui Y, Zou C, Jin J, Lv G, Peng Y, Wang L, et al. (2011). Coexpression of an intronic microRNA and its host gene reveals a potential role for miR-483-5p as an IGF2 partner. Mol Cell Endocrinol 333: 96-101.
20. Mayr C, Bartel DP. (2009). Widespread shortening of 39UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138: 673-684.
21. McGraw CM, Samaco RC, Zoghbi HY. (2011). Adult neural function requires MeCP2. Science 333: 186.
22. Meyer M, Kircher M, Gansauge MT, Li H, Racimo F, Mallick S, Schraiber JG, Jay F, Prufer K, de Filippo C, et al. (2012). A high-coverage genome sequence from an archaic Denisovan individual. Science 338: 222-226.
23. Nan X, Campoy FJ, Bird A. (1997). MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell 88: 471-481.
24. Nguyen MV, Du F, Felice CA, Shan X, Nigam A, Mandel G, Robinson JK, Ballas N. (2012). MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J Neurosci 32: 10021-10034.
25. Nudelman AS, DiRocco DP, Lambert TJ, Garelick MG, Le J, Nathanson NM, Storm DR. (2010). Neuronal activity rapidly induces transcription of the CREB-regulated microRNA-132, in vivo. Hippocampus 20: 492-498.
26. Ramocki MB, Peters SU, Tavyev YJ, Zhang F, Carvalho CM, Schaaf CP, Richman R, Fang P, Glaze DG, Lupski JR, et al. (2009). Autism and other neuropsychiatric symptoms are prevalent in individuals with MeCP2 duplication syndrome. Ann Neurol 66: 771-782.
27. Saba R, Schratt GM. (2010). MicroRNAs in neuronal development, function and dysfunction. Brain Res 1338: 3-13.
28. Samaco RC, Nagarajan RP, Braunschweig D, LaSalle JM. (2004). Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrumdisorders. Hum Mol Genet 13: 629-639.
29. Shahbazian MD, Antalffy B, Armstrong DL, Zoghbi HY. (2002). Insight into Rett syndrome: MeCP2 levels display tissue-and cell-specific differences and correlate with neuronal maturation. Hum Mol Genet 11: 115-124.
30. Van Esch H, Bauters M, Ignatius J, Jansen M, Raynaud M, Hollanders K, Lugtenberg D, Bienvenu T, Jensen LR, Gecz J, et al. (2005). Duplication of the MECP2 region is a frequent cause of severe mental retardation and progressive neurological symptoms in males. Am J Hum Genet 77: 442-453.
31. Weksberg R, Shuman C, Beckwith JB. (2010). Beckwith-Wiedemann syndrome. Eur J Hum Genet 18: 8-14.
32. Yoon HG, Chan DW, Huang ZQ, Li J, Fondell JD, Qin J, Wong J. (2003). Purification and functional characterization of the human N-CoR complex: The roles of HDAC3, TBL1 and TBLR1. EMBO J 22: 1336-1346.